Brief: BB Biotech 2022 Net Loss CHF 358 MLN
Feb 17 (Reuters) - BB BIOTECH AG BION.S :
* BB BIOTECH AG PUBLISHES ITS 2022 ANNUAL REPORT
* NET LOSS IN 2022 WAS CHF 358 MILLION
* FOR FULL YEAR, BB BIOTECH'S TOTAL SHARE RETURN WAS -24.3%
IN CHF
AND -19.0% IN EUR, SUBSTANTIALLY BEHIND PORTFOLIO PERFORMANCE OF
-11.0% IN CHF, -6.7% IN EUR AND -12.1% IN USD
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))